Sulindac sulfide is believed to mediate its antitumorigenic effects by inducing apoptosis through an up-regulated DR5 and activated caspase 8 in colon and prostate cancer cell lines [14]. This evidence concerns the gene TNFRSF10B and prostate cancer.